Laparoscopic Sleeve Gastrectomy (LSG) as a Therapeutic Strategy for the Management of Polycystic Ovarian Syndrome (PCOS) in Obese Patients

PCOS is the most common endocrine disorder in women of reproductive age with a prevalence of 6-10% and is often underreported. This syndrome negatively impacts reproductive (infertility, menstrual dysfunction, hirsutism, hyperandrogenism) and metabolic (insulin sensitivity, metabolic syndrome, Type 2 Diabetes mellitus [T2DM], dyslipidemia) health. PCOS confers increased risk of endometrial cancer, and increased mortality due to the T2DM, cancer, and cardiovascular disease. It has been noted to affect 28% of obese women. Emerging evidence suggests that bariatric surgery may be an effective therapeutic strategy for the management of PCOS.